Drug Type Diagnostic radiopharmaceuticals, Radionuclide Drug Conjugates (RDC) |
Synonyms technetium-99m-scVEGF-PEG-DOTA |
Target |
Action modulators |
Mechanism VEGFR1 modulators(Vascular endothelial growth factor receptor 1 modulators), VEGFR2 modulators(Vascular endothelial growth factor receptor 2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Arteriosclerosis | Preclinical | United States | - |